Vault-13

Sivik Global Healthcare LLC

GREENWICH, CT · CIK 1596452 · 13F filing filed 2026-07-20

SEC-registered investment adviser since 2014 · limited liability company

$131.7m reported value +0.0% vs Q1 2026
34positions
46.6%in top 10
0 new 0 added 0 reduced 0 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 SPDR SER TR S&P BIOTECH XBI XBI 150,000 $19.2m14.55% 14.55% UnchangedShares held: Q3 2025 250.0k, Q4 2025 225.0k, Q1 2026 150.0k, Q2 2026 150.0k
2 CARDINAL HEALTH INC COM CAH CAH 24,000 $5.1m3.85% 3.85% UnchangedShares held: Q3 2025 37.5k, Q4 2025 32.5k, Q1 2026 24.0k, Q2 2026 24.0k
3 CALL- BSX 100 @ 75 EXP 04/17/2026 CALL CALL 800 $5.0m3.81% 3.81% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 800, Q2 2026 800
4 JOHNSON & JOHNSON COM JNJ JNJ 20,000 $4.9m3.71% 3.71% UnchangedShares held: Q3 2025 25.0k, Q4 2025 0, Q1 2026 20.0k, Q2 2026 20.0k
5 MERCK & CO INC COM MRK MRK 40,000 $4.8m3.65% 3.65% UnchangedShares held: Q3 2025 0, Q4 2025 30.0k, Q1 2026 40.0k, Q2 2026 40.0k
6 CENCORA INC COM COR COR 15,000 $4.7m3.58% 3.58% UnchangedShares held: Q3 2025 20.0k, Q4 2025 18.0k, Q1 2026 15.0k, Q2 2026 15.0k
7 ELI LILLY & CO COM LLY LLY 5,000 $4.6m3.49% 3.49% UnchangedShares held: Q3 2025 10.0k, Q4 2025 7.0k, Q1 2026 5.0k, Q2 2026 5.0k
8 WATERS CORP COM WAT WAT 15,000 $4.5m3.39% 3.39% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 15.0k, Q2 2026 15.0k
9 VERTEX PHARMACEUTICALS INC COM VRTX VRTX 10,000 $4.5m3.39% 3.39% UnchangedShares held: Q3 2025 14.0k, Q4 2025 13.8k, Q1 2026 10.0k, Q2 2026 10.0k
10 INTUITIVE SURGICAL INC COM NEW ISRG ISRG 9,000 $4.1m3.15% 3.15% UnchangedShares held: Q3 2025 13.0k, Q4 2025 10.0k, Q1 2026 9.0k, Q2 2026 9.0k
11 ASTRAZENECA PLC ORD AZN AZN 20,000 $3.9m3.00% 3.00% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 20.0k, Q2 2026 20.0k
12 THERMO FISHER SCIENTIFIC INC COM TMO TMO 8,000 $3.9m2.99% 2.99% UnchangedShares held: Q3 2025 14.0k, Q4 2025 12.0k, Q1 2026 8.0k, Q2 2026 8.0k
13 BOSTON SCIENTIFIC CORP COM BSX BSX 62,000 $3.9m2.95% 2.95% UnchangedShares held: Q3 2025 70.0k, Q4 2025 70.0k, Q1 2026 62.0k, Q2 2026 62.0k
14 DANAHER CORPORATION COM DHR DHR 20,000 $3.8m2.88% 2.88% UnchangedShares held: Q3 2025 35.0k, Q4 2025 23.0k, Q1 2026 20.0k, Q2 2026 20.0k
15 TENET HEALTHCARE CORP COM NEW THC THC 20,000 $3.8m2.87% 2.87% UnchangedShares held: Q3 2025 35.0k, Q4 2025 37.5k, Q1 2026 20.0k, Q2 2026 20.0k
16 GILEAD SCIENCES INC COM GILD GILD 25,000 $3.5m2.65% 2.65% UnchangedShares held: Q3 2025 0, Q4 2025 25.0k, Q1 2026 25.0k, Q2 2026 25.0k
17 HUMANA INC COM HUM HUM 20,000 $3.5m2.63% 2.63% UnchangedShares held: Q3 2025 25.0k, Q4 2025 15.0k, Q1 2026 20.0k, Q2 2026 20.0k
18 METTLER TOLEDO INTERNATIONAL COM MTD MTD 2,750 $3.5m2.63% 2.63% UnchangedShares held: Q3 2025 0, Q4 2025 3.0k, Q1 2026 2.8k, Q2 2026 2.8k
19 MCKESSON CORP COM MCK MCK 4,000 $3.5m2.63% 2.63% UnchangedShares held: Q3 2025 7.0k, Q4 2025 9.0k, Q1 2026 4.0k, Q2 2026 4.0k
20 AGILENT TECHNOLOGIES INC COM A A 30,000 $3.4m2.60% 2.60% UnchangedShares held: Q3 2025 33.0k, Q4 2025 35.0k, Q1 2026 30.0k, Q2 2026 30.0k
21 STRYKER CORPORATION COM SYK SYK 10,000 $3.3m2.50% 2.50% UnchangedShares held: Q3 2025 13.0k, Q4 2025 13.0k, Q1 2026 10.0k, Q2 2026 10.0k
22 ABBVIE INC COM ABBV ABBV 15,000 $3.3m2.48% 2.48% UnchangedShares held: Q3 2025 20.0k, Q4 2025 20.0k, Q1 2026 15.0k, Q2 2026 15.0k
23 UNIVERSAL HLTH SVCS INC CL B UHS UHS 17,500 $3.1m2.38% 2.38% UnchangedShares held: Q3 2025 28.0k, Q4 2025 28.0k, Q1 2026 17.5k, Q2 2026 17.5k
24 REGENERON PHARMACEUTICALS COM REGN REGN 4,000 $3.1m2.35% 2.35% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 4.0k, Q2 2026 4.0k
25 BIO RAD LABS INC CL A BIO BIO 10,000 $2.8m2.12% 2.12% UnchangedShares held: Q3 2025 11.0k, Q4 2025 12.0k, Q1 2026 10.0k, Q2 2026 10.0k
26 BIOGEN INC COM BIIB BIIB 15,000 $2.8m2.09% 2.09% UnchangedShares held: Q3 2025 0, Q4 2025 20.0k, Q1 2026 15.0k, Q2 2026 15.0k
27 UNITEDHEALTH GROUP INC COM UNH UNH 10,000 $2.7m2.05% 2.05% UnchangedShares held: Q3 2025 12.0k, Q4 2025 12.0k, Q1 2026 10.0k, Q2 2026 10.0k
28 GLOBUS MED INC CL A GMED GMED 30,000 $2.6m1.96% 1.96% UnchangedShares held: Q3 2025 0, Q4 2025 40.0k, Q1 2026 30.0k, Q2 2026 30.0k
29 ABBOTT LABS COM ABT ABT 25,000 $2.6m1.95% 1.95% UnchangedShares held: Q3 2025 37.5k, Q4 2025 40.0k, Q1 2026 25.0k, Q2 2026 25.0k
30 EDWARDS LIFESCIENCES CORP COM EW EW 20,000 $1.6m1.22% 1.22% UnchangedShares held: Q3 2025 0, Q4 2025 35.0k, Q1 2026 20.0k, Q2 2026 20.0k
31 SMITH & NEPHEW PLC SPDN ADR NEW SNN SNN 50,000 $1.6m1.21% 1.21% UnchangedShares held: Q3 2025 160.0k, Q4 2025 125.0k, Q1 2026 50.0k, Q2 2026 50.0k
32 ELEVANCE HEALTH INC COM ELV ELV 5,000 $1.5m1.11% 1.11% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 5.0k, Q2 2026 5.0k
33 ENCOMPASS HEALTH CORP COM EHC EHC 15,000 $1.5m1.10% 1.10% UnchangedShares held: Q3 2025 35.0k, Q4 2025 50.0k, Q1 2026 15.0k, Q2 2026 15.0k
34 CVS HEALTH CORP COM CVS CVS 20,000 $1.4m1.09% 1.09% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 20.0k, Q2 2026 20.0k